Sugemalimab, developed using CStone’s OmniRat transgenic platform, is a fully human IgG4 monoclonal antibody designed to minimize immunogenicity and toxicity
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Prolia is a prescription medicine used to treat osteoporosis in women
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
Subscribe To Our Newsletter & Stay Updated
